Whereas PTEN mutations were identified in four out of 183 breast cancers (2.2%), PIK3CA mutations were found in 63 out of 220 (29%), and TP53 mutations in 92 out of 253 (36%) tumors analyzed (Table 1). This evidence concerns the gene PIK3CA and breast cancer.